C. Berkowski

Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients

Julia Dietz, S. Süsser, C. Berkowski et al. · PLoS ONE · 2015 · 74 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses

Amare Aregay, Solomon Owusu Sekyere, Katja Deterding et al. · Journal of Hepatology · 2019 · 71 citations

Life Sciences, Immunology, Infectious Diseases +15

Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection

Georgios Grammatikos, Nerea Ferreirós, Dimitra Bon et al. · Hepatology · 2014 · 50 citations

Medicine, Biochemistry, Pathology +17

Interferon lambda 4 genotypes and resistance‐associated variants in patients infected with hepatitis C virus genotypes 1 and 3

Kai‐Henrik Peiffer, Lisa Sommer, S. Süsser et al. · Hepatology · 2015 · 46 citations

Life Sciences, Genetics, Molecular Genetics +17

Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection

Johannes Vermehren, Benjamin Maasoumy, Raoel Maan et al. · Clinical Infectious Diseases · 2016 · 25 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +17